Investitionsthese
mediaire invests in life science startups with a focus on precision medicine, digital health, and innovative medical technologies. The firm targets companies addressing high unmet medical needs across pharmaceuticals, MedTech, and diagnostics.
Investitionsphase
Pre-Seed, Seed
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Life science startups, precision medicine, digital health applications, medical devices, and diagnostics
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€800.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (19)
B
Brigitte Reischl
Contact / Representative
C
Christian Rozsenich
Contact / Representative
C
Clemens von Bergmann
Investment Director / Procurist
C
Curtis MacDonald
Venture Partner
D
Dr. Angelika Vlachou
Partner
D
Dr. Koen Geurts
Investment Manager
F
Ferry Wecken
Private Investor
H
High-Tech Gründerfonds
Investor
I
Ina Wecken
Private Investor
J
Johannes Dierkes
Investment Manager
K
Kilian von Berlichingen
Investment Professional
K
Klaus Wecken
Private Investor
L
Louis Heinz
Investment Professional
P
Prof. Dr. Conen
Investor
S
Sebastian Borek
Investment Professional
S
Steffen Gruber
Contact / Representative
T
Tanja Emmerling
Investment Professional
W
Wolfgang Kitza
Managing Director / CEO
Y
Yann Fiebig
Partner
